Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5717411-(4-aminophenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-oneMeSH

  structure in first source

• C5825451-(4-benzoyl-piperazin-1-yl)-2-(4-fluoro-7-(1,2,3)triazol-1-yl-1H-pyrrolo(2,3-c)pyridin-3-yl)-ethane-1,2-dioneMeSH

  virus attachment inhibitor; structure in first source

• C5705461-(4-benzylpiperidin-1-yl)-2-(6-hydroxy-1H-indol-3-yl)ethane-1,2-dioneMeSH

  an NMDA receptor ligand; structure in first source

• C5606581-(4-beta-D-glucopyranosyloxyphenyl)-2-(beta-D-glucopyranosyloxy)-ethaneMeSH

  structure in first source

• C5847461-(4-biphenylyl)-3-(1H-imidazol-1-yl)-1-propanoneMeSH

  structure in first source

• C5747011-(4-carbamoylpyridinium)-4-(3-fluoro-4-hydroxyiminomethylpyridinium)-but-2-eneMeSH

  reactivates tabun-inhibitor acetylcholinesterase; structure in first source

• C5726201-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-cyano-4-hydroxyphenyl)ureaMeSH

  structure in first source

• C5728811-(4-chlorophenyl)-3-(4-nitrophenyl)triazeneMeSH

  structure in first source

• C5839161-(4-ethoxyphenyl)-3-(4-nitrophenyl)-prop-2-en-1-oneMeSH

  structure in first source

• C5824171-(4-fluoro-3-methoxybenzyl)-N-(9-chloro-3,4-dihydro-2H-1,5-benzodioxepin-7-ylmethyl)-N-isobutylpyrrolidine-3-carboxamideMeSH
• C5706881-(4-fluorobenzoyl)-3-(((6-methoxy-2-naphthyl)oxy)methyl)azetidine-3-carboxylic acidMeSH

  structure in first source

• C5751801-(4-fluorophenyl)-2-oxo-N-(4-((2-(thiophen-3-yl)-3H-imidazo(4,5-b)pyridin-7-yl)oxy)phenyl)-1,2-dihydropyridine-3-carboxamideMeSH

  a c-Met kinase inhibitor; structure in first source

• C5736431-(4-fluorophenyl)-8-(2-(4-fluorophenyl)-2-hydroxycyclohexyl)-1,3,8-triazaspiro(4.5)decan-4-oneMeSH

  inhibits glycine transporter-1

• C5742431-(4-fluorophenylthiocarbamoyl)-4-methylpiperazineMeSH

  reduces cytotoxic and genotoxic effects of paraquat in Hordeum vulgare and cultured human lymphocytes; structure in first source

• C5774671-(4-imidazopyridinyl-7-phenyl)-3-(4'-cyanobiphenyl)ureaMeSH

  inhibits CYP3A4; structure in first source

• C5783181-(4-methoxybenzyl)-2-(4-methoxyphenyl)-1H-benzo(d)imidazoleMeSH

  structure in first source

• C5831611-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidMeSH

  has been shown to exhibit unprecedented positive allosteric activity for ACh binding as well as inherent agonist activity at the M1 muscarinic receptor; structure in first source

• C5879231-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dioneMeSH
• C5842881-(4-methoxyphenylethyl)-11H-benzo(f)-1,2-dihydropyrido(3,2,c)(1,2,5)oxathiazepine 5,5 dioxideMeSH

  structure in first source

• C5781931-(4-methyl-3-(2-methyl-4-(4-methyl-2H-pyrazol-3-yl)-quinolin-8-yloxymethyl)pyridin-2-ylmethyl)-3-trifluoromethyl-1H-pyridin-2-oneMeSH

  structure in first source

• C5745131-(4-morpholinophenyl)-3-(3-fluorophenyl)propenoneMeSH

  structure in first source

• C5745141-(4-morpholinophenyl)-3-(4-fluorophenyl)propenoneMeSH

  structure in first source

• C5622461-(4-nitro-2-(trifluoromethyl)phenyl)-4-(3-(trifluoromethyl)phenyl)piperazineMeSH

  for treatment of benign prostatic hyperplasia; structure in first source

• C5833911-(4-octylphenethyl)piperidin-4-olMeSH

  structure in first source

• C5772171-(4-phenyl-cyclohex-1-enyl)-pyrrolidineMeSH

  structure in first source

• C5778541-(4-trifluoromethoxyphenyl)-3-(4-(5-trifluoromethyl-2,5-dihydropyrazol-1-yl)phenyl)ureaMeSH

  has antineoplastic activity; structure in first source

• C5843121-(4-tritylphenyl)pyrrole-2,5-dioneMeSH

  structure in first source

• C5863381-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-enyl-3-(3-(trifluoromethyl)phenyl)acrylateMeSH

  structure in first source

• C5708951-(5-((2,4-difluorophenyl)thio)-4-nitrothiophen-2-yl)ethanoneMeSH

  a USP7 inhibitor; structure in first source

• C5863301-(5-((3,3-difluoropyrrolidin-1-yl)carbonyl)pyrrolidin-3-yl)-4-(4-fluoro-3-methylphenyl)-1H-1,2,3-triazoleMeSH

  structure in first source

• C5863321-(5-((3,3-difluoropyrrolidin-1-yl)carbonyl)pyrrolidin-3-yl)-4-(4-phenylphenyl)-1H-1,2,3-triazoleMeSH

  structure in first source

• C5789741-(5-(4-((2-acetylphenyl)carbamoyl)phenoxy)pentyl)quinolin-1-iumMeSH

  structure in first source

• C5862821-(5-(4-methoxy-phenyl)-(1,3,4)oxadiazol-2-yl)-piperazineMeSH

  structure in first source

• C5782601-(5-(5-chloro-2-hydroxyphenyl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanoneMeSH

  a BRAF kinase inhibitor; structure in first source

• C5735591-(5-(7-(3-morpholinopropoxy)quinazolin-4-ylthio)-(1,3,4)thiadiazol-2-yl)-3-p-tolylureaMeSH

  an FLT3 inhibitor with antineoplastic activity; structure in first source

• D0193071-(5-Isoquinolinesulfonyl)-2-MethylpiperazineMeSH

  A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.

• C5702861-(5-bromo-2-hydroxy-4-methoxyphenyl)ethanoneMeSH

  an anti-inflammatory agent isolated from the sea horse Hippocampus kuda; structure in first source

• C5750501-(5-chloro-2-methyl-phenyl)-3-(4-(5-trifluoromethyl-pyrazol-1-yl)-phenyl)thioureaMeSH

  antineoplastic; structure in first source

• C5598531-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acidMeSH

  inhibits hypoxia-inducible factor prolyl hydroxylase; structure in first source

• C5711261-(5-chloropyridin-3-yl)-(1,4)diazepaneMeSH

  an alpha4beta2 nicotinic receptor partial agonist; structure in first source

• C5615871-(5-ethoxypyridin-3-yl)-1,4-diazepaneMeSH

  an alpha4beta2 acetylcholine receptor partial agonist; structure in first source

• C5823371-(5-fluoropentyl)-3-(1-naphthoyl)indoleMeSH

  a cannabimimetic; structure in first source

• C5830001-(6-(2-(4-(2-dimethylaminoethoxy)phenyl)-5-(pyridin-4-yl)-1H-imidazol-4-yl)benzo(b)thiophen-3-yl)-2,2,2-trifluoroethanolMeSH

  structure in first source

• C5856561-(6-(3,5-dichloro-4-hydroxyphenyl)-4-((4-((dimethylamino)methyl)cyclohexyl)amino)-1,5-naphthyridin-3-yl)ethanoneMeSH

  a MELK inhibitor; structure in first source

• C5773311-(6-hydroxymethylinositol)-2-O-methyl-3-O-octadecyl-sn-glycerocarbonateMeSH

  an Akt inhibitor

• C5857361-(6-methoxy-2H-chromen-3-yl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-oneMeSH

  structure in first source

• C5718341-(7-(2-amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-3,4-dihydroisoquinolin-2(1H)-yl)-2-cyclopentylethanoneMeSH

  a histamine H4 receptor antagonist with antipruritic and anti-inflammatory activities; structure in first source

• C5839041-(7-azabenzobicyclo(2.2.1)heptane)diazen-1-ium-1,2-diolMeSH

  structure in first source

• C5792511-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-olMeSH

  a cardiovascular agent; structure in first source

• C5692381-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-yl)cyclohexanolMeSH